Skip to main content
. 2009 Aug 5;106(33):14022–14027. doi: 10.1073/pnas.0903201106

Table 1.

Myocardial Infarct Phenotype before and 12 weeks after treatment

Parameter Groups Week 12 Week 24 P
MI Size, %LV mass Placebo 19.6 ± 1.5 20.6 ± 1.1 0.76
MSC 19.3 ± 1.7 13.9 ± 2.0 <0.001*
Infarct volume, mL Placebo 7.1 ± 0.4 8.0 ± 0.4 0.06
MSC 7.4 ± 1.2 5.4 ± 1.1 <0.001
LV mass, g Placebo 36.5 ± 1.9 39.0 ± 0.6 0.75
MSC 37.1 ± 3.2 37.5 ± 2.6 0.58
Circumferential extent of MI, % LV Placebo 40.1 ± 2.8 40.3 ± 2.8 0.73
MSC 42.1 ± 2.1 28.0 ± 2.8 <0.001*
Wall thickness infarct, mm Placebo 4.0 ± 0.1 3.6 ± 0.2 0.12
MSC 3.9 ± 0.2 4.9 ± 0.4 0.049*
Wall thickness remote, mm Placebo 7.1 ± 0.5 7.4 ± 0.5 0.69
MSC 6.6 ± 0.5 6.9 ± 0.3 0.62

*ANOVA between groups.

ANOVA within groups.

HHS Vulnerability Disclosure